B+L unveils latest contact lenses

B+L unveils latest contact lenses

By Martin Burns

The latest contact lenses from Bausch + Lomb (B+L) have been revealed, which the organisation claims will help to benefit people who suffer from keratoconus.

According to B+L, the Kerasoft IC silicone hydrogel contact lenses can treat patients with keratoconus and other irregular cornea conditions and are now being rolled out in the US, with a view to worldwide roll-out.

Irregular corneas can be caused by a number of factors including disease, trauma, corneal transplants and complicated laser surgery, and in many cases these patients can have considerably reduced vision that is not adequately addressed by standard vision correction.

This is because standard glasses do not successfully address the complexities of an eye with an irregular cornea or keratoconus, with patients traditionally limited to gas permeable lenses which offer reduced wearing time.

However, David Bland, director of Global GP and the Custom Soft Lens Business for B+L, explained that KeraSoft IC lenses are designed to fit irregular corneas, including keratoconus, post laser refractive surgery, pellucid marginal degeneration, and other complex corneal irregularities.

He noted that each KeraSoft IC lens is custom-made for a patient's exact needs and has a patented combination of the latest technologies in silicone hydrogel materials using geometries from complex mathematics to offer comfortable wear.

As a result it offers increased wear time and improved comfort for patients, with the technology recognised with the UK's Queen's Award for Enterprise and Innovation.

Mr Bland commented: "Through our manufacturing and distribution agreement with our lab channel partners, Bausch + Lomb is proud to offer KeraSoft IC lenses as an option to eyecare professionals for their patients with irregular corneas."

He added that, once vision experts have the opportunity to learn more about KeraSoft IC lenses and participate in training to fit them, he expects the new products to become an "excellent option" for helping patients with irregular corneas.

by Adrian Galbreth

« Back to list